BioSpace News Archive

Exagen Inc.is proud to announce the company’s stockholders approved the election of Mr. Frank Stokes as an additional independent member to its Board of Directors at the Annual Meeting held on June 17, 2021.

Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted ADLT status for the Signatera molecular residual disease (MRD) test.

Ampio Pharmaceuticals announced that the Company is expected to join the small cap Russell 2000® Index and the broad-market Russell 3000® Index at the conclusion of this year’s reconstitution of the Russell stock indexes, effective after the U.S. stock market opens on Monday, June 28, 2021, accordingly to a preliminary list of additions posted on June 4, 2021.

Praetego Inc (https://www.praetego.com/), a pharmaceutical company committed to improving health outcomes for patients living with diabetes, is pleased to announce a $0.46M funding award from the National Institutes of Health.

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ SARS-CoV-2 DS (Direct Saliva) has obtained regulatory authorization to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of COVID-19 in markets that accept CE markings

Reference is made to the stock exchange notice published 2 June 2021 regarding allocation of restricted stock units to members of the board of directors of Nordic Nanovector ASA.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced Health Canada has granted Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF) in people ages 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the most common CF-causing mutation.

According to The Insight Partners market research study of Brain Aneurysm Treatment Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Type, Condition, and End User.

Arena Pharmaceuticals, Inc. announced that on June 15, 2021, the Compensation Committee of its Board of Directors granted to 17 new employees inducement stock options to purchase an aggregate of 64,401 shares of its common stock and 27,857 inducement restricted stock units.

IMV Inc., a clinical-stage biopharmaceutical company, announced the voting results from its annual and special meeting of shareholders held on June 18, 2021.